ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer
Open Access
- 6 September 2024
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 63 (12) , 2401-2413
Abstract
The role of adenosine deaminase acting on RNA1 (ADAR1) in colorectal cancer (CRC) is poorly understood. This study investigated the roles and underlying molecular mechanisms of ADAR1 and its isoforms, explored the correlations between ADAR1 expression and the immune microenvironment and anticancer drug sensitivity, and examined the potential synergy of using ADAR1 expression and clinical parameters to determine the prognosis of CRC patients. CRC samples showed significant upregulation of ADAR1, and high ADAR1 expression was correlated with poor prognosis. Silencing ADAR1 inhibited the proliferation, invasion, and migration of CRC cells and induced ferroptosis by suppressing FAK/AKT activation, and the results of rescue assays were consistent with these mechanisms. Both ADAR1‐p110 and ADAR1‐p150 were demonstrated to regulate the FAK/AKT pathway, with ADAR1‐p110 playing a particularly substantial role. In evaluating the prognosis of CRC patients, combining ADAR1 expression with clinical parameters produced a substantial synergistic effect. The in vivo tumorigenesis of CRC was significantly inhibited by silencing ADAR1. Furthermore, ADAR1 expression was positively correlated with tumor mutational burden (TMB) and microsatellite status (p < 0.05), indicating that ADAR1 plays a complex role in CRC immunotherapy. In conclusion, ADAR1 plays oncogenic roles in CRC both in vitro and in vivo, potentially by inhibiting ferroptosis via downregulation of the FAK/AKT pathway. Thus, ADAR1 serves as a potential prognostic biomarker and a promising target for CRC therapy.Keywords
This publication has 53 references indexed in Scilit:
- Loss of ADAR1 induces ferroptosis of breast cancer cellsCellular Signalling, 2024
- Overcoming cancer chemotherapy resistance by the induction of ferroptosisDrug Resistance Updates, 2022
- Targeting ferroptosis to treat colorectal cancerTrends in Cell Biology, 2022
- Ferroptosis in cancer and cancer immunotherapyCancer Communications, 2022
- Ferroptosis, radiotherapy, and combination therapeutic strategiesProtein & Cell, 2021
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint BlockadeCell, 2019
- Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA DamageMolecular Cell, 2018
- Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activationCancer Letters, 2017
- Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in TumorsCell Reports, 2015
- The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersCancer Cell, 2015